← back to search

Sandhya Bangaru

Scripps Research Institute · US
Area of research
Infectious Diseases · Animal Science and Zoology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Monoclonal and Polyclonal Antibodies Research, and Influenza Virus Research Studies.
h-index
22
citations
3,929
works
64
NIH funding
primary concept
Medicine
email

Recent publications

Microfluidics combined with electron microscopy for rapid and high-throughput mapping of antibody–viral glycoprotein complexes
Nature Biomedical Engineering 2025cited by 7position: middledoi
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies
iScience 2024cited by 5position: middledoi
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
iScience 2023cited by 14position: middledoi
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Science Translational Medicine 2021cited by 136position: middledoi
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Cell Host & Microbe 2021cited by 70position: middledoi
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Science 2020cited by 1,344position: middledoi
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Immunity 2020cited by 237position: middledoi
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
Cell Reports 2020cited by 194position: middledoi
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
Cell 2019cited by 266position: firstdoi
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
Cell Host & Microbe 2019cited by 70position: middledoi
Recognition of influenza H3N2 variant virus by human neutralizing antibodies
JCI Insight 2016cited by 25position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew B. Ward · Scripps (United States)8 papers (2016–2025)Xueyong Zhu · Scripps Research Institute5 papers (2019–2021)Ian A. Wilson · Raigmore Hospital5 papers (2019–2021)Rogier W. Sanders · Scripps Research Institute4 papers (2020–2023)Marit J. van Gils · Amsterdam University Medical Centers4 papers (2020–2023)Meng Yuan · Ministry of Education of the People's Republic of China3 papers (2020–2021)Nicholas C. Wu · University of Illinois Urbana-Champaign3 papers (2020–2021)James E. Crowe · Vanderbilt University Medical Center3 papers (2016–2019) · 3 papers (2016–2019)Chang‐Chun D. Lee · Scripps Research Institute3 papers (2020–2021)Jonathan L. Torres · Scripps Research Institute3 papers (2020–2023)Hejun Liu · Ministry of Agriculture and Rural Affairs3 papers (2020–2021)Pavlo Gilchuk · AstraZeneca (Japan)2 papers (2019–2019)Kathryn M. Edwards · Compliant Concept2 papers (2016–2019)Hannah L. Turner · International AIDS Vaccine Initiative2 papers (2019–2019) · 2 papers (2016–2019)Dennis R. Burton · Scripps Research Institute2 papers (2021–2025) · 2 papers (2019–2019)Tom G. Caniels · Amsterdam University Medical Centers2 papers (2020–2020)Sheng Li · Sun Yat-sen University2 papers (2019–2019)